The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is part of The Ohio State University and one of the 45 National Comprehensive Cancer hospitals. It is named after Arthur G. James, the founder, who desired a cancer hospital in Columbus, Ohio, United States.

There are 306 beds in Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent.

During the past decade, Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent" are "IgA Nephropathy" (1 trials) and "Locally Advanced Rectal Cancer" (1 trials). Many other conditions were trialed in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent" in a lesser frequency.

Most popular intervention types in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atacicept 25 mg" (1 trials), "Atacicept 75 mg" (1 trials), "Capecitabine" (1 trials), "Peposertib 100 mg" (1 trials) and "Peposertib 150 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".